期刊文献+

NF-κBp65、EGFR、P16在宫颈腺癌中的表达及临床意义 被引量:3

Expressions and clinical significances of NF-κBp65,EGFR,and P16 in cervical adenocarcinoma
原文传递
导出
摘要 目的:研究NF-κBp65、EGFR及P16在宫颈腺癌中的表达及其意义。方法:应用免疫组化法检测宫颈腺癌及正常宫颈组织中NF-κBp65、EGFR及P16蛋白表达情况,并分析其与临床病理参数的关系。结果:在宫颈腺癌组织中NF-κBp65、EGFR及P16蛋白表达率与正常宫颈组织中的NF-κBp65、EGFR及P16表达率比较差异有统计学意义(P<0.05);NF-κBp65蛋白的表达与淋巴管浸润及淋巴结转移有关(P<0.05),与其他病理参数无关(P>0.05);EGFR蛋白的表达与临床病理参数均无关(P>0.05);P16蛋白的表达与组织学分级有关(P<0.05),与其他病理参数无关(P>0.05)。NF-κBp65的表达与EGFR的表达呈正相关(r=0.359,P<0.05),NF-κBp65的表达与P16的表达无相关性(r=-0.307,P>0.05),EG-FR的表达与P16的表达呈正相关(r=0.379,P<0.05)。结论:NF-κBp65、EGFR及P16蛋白的表达与宫颈腺癌的发生和进展有一定的相关性,P16蛋白可以作为宫颈腺癌早期诊断的肿瘤标记物。 Objective: To explore the expressions and significances of NF - κBp65, epidermal growth factor receptor .( EGFR), and P16 in cervical adenocareinoma. Methods: The expressions of NF-κBp65 protein, EGFR protein, and P16 protein in cervical adeno- carcinoma and normal cervix were detected by immunohistochemical method, and their correlations with clinicopathologieal parameters were analyzed. Results: There were statistically significant differences in expression rates of NF - κBp65 protein, EGFR protein, and P16 protein between cervical adenocarcinoma group and normal cervix group ( P 〈 0. 05 ) . The expression of NF - κBp65 protein was significantly corre- lated with lymphatic vessel invasion and lymph node metastasis ( P 〈 0. 05 ), there was no correlation between expression of NF - κBp65 pro- tein and other pathological parameters ( P 〉 0. 05 ) . There was no correlation between expression of EGFR protein and other clinicopatholog- ical parameters (P 〉 0. 05 ) . The expression of P16 protein was correlated with histological grades (P 〈 0. 05 ), but there was no correlation between expression of P16 protein and other pathological parameters (P 〉 0. 05 ) . There was a positive correlation between NF - KBp65 ex- pression and EGFR expression ( T = 0. 359, P 〈 0. 05 ), there was no correlation between NF - KBp65 expression and P16 expression (r = -0. 307, P 〉 0. 05), there was a positive correlation between EGFR expression and P16 expression (T = 0. 379, P 〈 0. 05) . Conclusion: There was a certain correlation between expressions of NF - κBp65 protein, EGFR protein, P16 protein and oneogenesis and devel- opment of cervical adenocarcinoma. P16 protein can be used as a marker for early diagnosis of cervical adenoeareinoma.
出处 《中国妇幼保健》 CAS 北大核心 2013年第6期1007-1010,共4页 Maternal and Child Health Care of China
基金 四川省卫生厅项目〔川卫办(2007)431号〕
关键词 核因子-ΚB 表皮生长因子受体 P16 宫颈腺癌 NF - κBp65 Epidermal growth factor receptor P16 Cervical adenoearcinoma
  • 相关文献

参考文献10

  • 1Melo AC,Advíncula G.H,Carmo CC et al.Survival and clin-ic pathologic characteristics of invasive adenocarcinoma of the uterine cervix(J).Journal of Clinical Oncology,2008,26(15S):16559.
  • 2Matthew S,Hayden,Sankar Ghosh.NF-κB,the first quar-ter-century:remarkable progress and outstanding questions(J).Genes Dev,2012,26:2038.
  • 3Mahmoodzadeh S,Fritschka S,Dworatzek E et al.Nuclear factor-B regulates estrogen receptor-transcription in the hu-man heart(J).J Biol Chem,2009,284:24705.
  • 4Oreste S,Sergio A,Stefano.Regulation of epidermal growth factor receptor signalling by inducible feedback inhibitors(J).J Cell Sci,2011,124:1785.
  • 5Berasain A,Perugorria MJ,Maria UL et al.The epidermal growth factor receptor:a link between inflammation and liver cancer(J).Exp Biol Med,2009,234:713.
  • 6冯淑瑜,邓玲红,康佳丽,夏薇,张彦娜,李莉平,程海燕,孙晋瑞,孙学明.表皮生长因子受体表达与高危型人乳头状瘤病毒载量在宫颈癌及癌前病变中的相关性[J].中国妇幼保健,2010,25(30):4456-4458. 被引量:7
  • 7: AMntonio J,Aik CT,Jordy C et al.Coordinated epidermal growth factor receptor pathway gene overexpression predictsepidermal growth factor receptor inhibitor sensitivity in pancre-atic cancer(J).Cancer Res,2008,68:2841.
  • 8Klaus B,Peter L,Oliver K et al.Expression of p16 protein and epidermal growth factor receptor in patients with adenocar-cinoma of the uterine cervix:an immunohistochemical analysis(J).Arch Gynecol Obstet,2011,283:611.
  • 9Masoudi H,Van DJ,Gilks CB et al.Loss of p16 INK4 ex-pression in invasive squamous cell carcinoma of the uterine cervix is an adverse prognostic marker(J).Histopathology,2006,49(5):542.
  • 10Huang LW,Lee CC.P16INK4A overexpression predicts lymph node metastasis in cervical carcinomas(J).J Clin Pathol,2012,65:117.

二级参考文献10

  • 1Lee CM, Lee RJ, Hammond E et al. Expression of HER2neu ( c - erbB-2) and epidermal growth factor receptor in cervical cancer: prognostic correlation with clinical characteristics, and comparison of manual and automated imaging analysis [J]. Gynecologic Oncology, 2004, 93 ( 1 ) : 209.
  • 2Anderson SM. Human papillomavirus and cervical cancer [J]. Clinical Microbiology Newsletter, 2002, 24 (15): 113.
  • 3Zhang B, Srirangam A, Potter DA et al. HPV16 E5 protein disrupts the c - Cbl - EGFR interaction and EGFR ubiquitination in human foreskin keratinoeytes [J]. Oneogene, 2005,24 ( 15 ) : 2585.
  • 4Genther Williams SM, Disbrow GL, Schlegel R et al. Requirement of epidermal growth factor receptor for hyperplasia induced by E5, a high- risk human papillomavirus oncogene [J]. Cancer Research, 2005, 65 (15): 6534.
  • 5Akerman GS, Tolleson WH, Brown KL et al. Human papillomavirus type 16 E6 and E7 cooperate to increase epidermal growth factor receptor (EGFR) mRNA levels, overcoming mechanisms by which excessive EGFR signaling shortens the life span of normal human keratinocytes [J]. Cancer Research, 2001, 61 : 3837.
  • 6Kedzia W, Schmidt M, Frankowski A et al. Immunohistochemical assay of p53, cyelin D1, c - erbB2, EGFr and Ki - 67 proteins in HPV - positive and HPV - negative cervical cancers [J]. Folia Histochem Cytobiol, 2002, 40 (1): 37.
  • 7Ngan HY, Cheung AN, Liu SS et al. Abnormal expression of epidermal growth factor receptor and c - erbB2 in squamous cell carcinoma of the cervix: correlation with human papillomavirus and prognosis [J]. Tumour Biol, 2001, 22 (3) : 176.
  • 8Follen M, Schottenfeld D. Surrogate endpoint biomarkers and their modulation in cervical chemoprevention trials [J]. Cancer, 2001, 91 (9): 1758.
  • 9冯淑瑜,张彦娜,刘继红,刘建刚,严鸣.宫颈癌和宫颈上皮内瘤变中表皮生长因子受体表达与人乳头瘤病毒16和(或)18感染及其相互关系[J].中华肿瘤杂志,2007,29(10):759-763. 被引量:10
  • 10邓玲红,冯淑瑜,康佳丽,张彦娜,林乔儿,聂妙玲,程海燕,孙晋瑞.宫颈癌中表皮生长因子受体的表达与临床预后的相关性研究[J].中国综合临床,2009,25(6):590-592. 被引量:3

共引文献6

同被引文献44

  • 1杜芸,王小玲,吴国祥,王永军,杨会钗,左连富.流式细胞术对食管癌组织中四种细胞周期调控蛋白的定量检测及意义[J].中华肿瘤杂志,2004,26(10):612-614. 被引量:8
  • 2林贞花,柳明沫,赵祎玮,吴群英,刘双平,金仁仙.人乳头状瘤病毒阴性的宫颈癌及其癌前病变中p16^(INK4A)蛋白表达和DNA倍体分析[J].中华病理学杂志,2006,35(7):412-416. 被引量:13
  • 3黎丹戎,张汉英,张玮,李力,黄昕昕.汉黄芩素对人卵巢癌细胞株SKOV3裸鼠移植瘤生长及端粒酶活性的抑制作用[J].中国药理学通报,2007,23(4):534-538. 被引量:28
  • 4宋超,刘霞,邵启祥,等.黄芩素埘肝癌HepG2细胞增殖和凋亡的影响及miR-34a在其机制中的作用[J].汀苏大学学报(医学版),2011.21(6):470.
  • 5Chen J, Li Z, Chen AY, et al baicalein on ovarian cancer cells[J]. Inhibitory effect of baiealin and International Journal of Molecular Sciences, 2013, 14(3): 6012-6025.
  • 6Damodaran S, Olson E. Targeting the human epidermal growth factor receptor 2 pathway in breast cancer[J]. Hospital Pr:tice, 2012, 40 (4): 7-15.
  • 7Chen S, Yang Z, Zhang Y, et al. Genomic amplification pat- terns of human telomerase RNA gene and C - MYC in liquid - based cytological specimens used for the detection of high - grade cervical intraepithelial neoplasia [J] . Diagn Pathol, 2012, 7 (1): 40.
  • 8Polyak K, Lee MH, Erdjument - Bromage H, et al. Cloning of p27Kipl, a cyclin - dependent kinase inhibitor and a poten- tial mediator of extracellular antimitogenic signals [J] . Cell, 1994, 78 (1) :59 -66.
  • 9Filipits M, Rudas M, Heinzl H, et al. Low p27 expression predicts early relapse and death in postmenopausal hormone re- ceptor- positive breast cancer patients receiving adjuvant tamoxifen therapy [J] . Clin Cancer Res, 2009, 15 (18) : 5888 - 5894.
  • 10Masoudi H, Van Niekerk DJ, Gilks CB, et al. Loss of p16 INK4 expression in invasive squamous cell carcinoma of the u- terine cervix is an adverse prognostic marker [ J] . Histopa- thology, 2006, 49 (5) :542- 545.

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部